WebApr 11, 2024 · Six transmembrane epithelial antigen of the prostate 1 (STEAP1) is a cell surface antigen for therapeutic targeting in prostate cancer. Here, we report broad expression of STEAP1 relative to ... WebAug 9, 2024 · Cyclophosphamide was given orally 50 mg per day together with low dose of corticosteroids, namely dexametasone orally 1 mg per day or prednisone 10 mg per day. Seventeen patients (51%) showed a PSA decline≥ 50%. Median progression-free survival (PFS) and overall survival (OS) were 11 and 28 months, respectively.
Treatment by Cancer Type - NCCN
WebMar 26, 2024 · B lymphoma cells are more sensitive to macrophages in the presence of rituximab. 164 Its combination with cyclophosphamide induced nearly complete tumor elimination in resistant bone marrow by... WebCyclophosphamide is used to treat breast cancer, lung cancer, leukaemia, lymphoma and myeloma. It may sometimes be used to treat other cancers. It is best to read this … home health care providers michigan
Metronomic chemotherapy with cyclophosphamide plus low …
WebAug 25, 2003 · The regimen of low-dose cyclophosphamide and dexamethasone demonstrated clinical response in patients with hormone-refractory prostate carcinoma … WebSep 15, 2005 · This protocol establishes a model that will test the hypothesis that the use of etoposide and cyclophosphamide early in the course of prostate cancer progression, when fewer tumor cells are present, will have greater anti-tumor activity. We plan to treat patients with stage D0 prostate cancer to assess toxicity and anti-tumor activity. Study … WebJul 15, 2024 · Breast, prostate, and lung cancer were among the top five most diagnosed cancers worldwide in 2024, while endometrial and ovarian cancer were the most common and deadly gynecologic malignancies in Europe [].Despite the emergence of new targeted therapies such as immunotherapy, hormonal therapies, tyrosine kinase, and poly (ADP … home health care providers houston